Outcomes related to 4864 pregnancies with exposure to lopinavir/ritonavir (LPV/r)

Lignende værker

• Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland
  af: Tookey, Pat A., et al.
  Udgivet: (2016)
• Pregnancy outcomes in women growing up with perinatally acquired HIV in the United Kingdom and Ireland
  af: Byrne, Laura, et al.
  Udgivet: (2014)
• 144-week outcomes of lopinavir/ritonavir (LPV/r)-based first-line ART in 1,409 HIV-infected patients: data from the German STAR/STELLA cohort
  af: Wolf, Eva, et al.
  Udgivet: (2014)
• Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients
  af: Berno, Giulia, et al.
  Udgivet: (2014)
• A comparison of the FDA TLOVR and FDA Snapshot algorithms based on studies evaluating once-daily vs. twice daily lopinavir/ritonavir (LPV/r) regimens
  af: Qaqish, R, et al.
  Udgivet: (2010)